Evidence map›Paper›PMID 37801118›Full record

ArticleAnalytical and bioanalytical chemistry2023

Near-infrared molecular sensor for visualizing and tracking ONOO

Xiangbao Liu, Yukun Ma, Yitong Liu, Qi Li, Hongguang Zhang, Shuang Fu, Song Chen, Hongmei Li, Shuang Li, Peng Hou

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. An imidazo-pyridin derivative as fluorescent probe for the peroxynitrite detection in pulmonary permissive hypercapnia.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Xiangbao LiuCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, People's Republic of China.
Yukun MaResearch Institute of Medicine & Pharmacy, Qiqihar Medical University, Qiqihar, 161006, People's Republic of China.
Yitong LiuCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, People's Republic of China.
Qi LiCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, People's Republic of China.
Hongguang ZhangCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, People's Republic of China.
Shuang FuCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, People's Republic of China.
Song ChenCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, People's Republic of China.
Hongmei LiCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, People's Republic of China.
Shuang LiCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, People's Republic of China.
Peng HouCollege of Pharmacy, Qiqihar Medical University, Qiqihar, 161006, People's Republic of China. houpeng1982@163.com.

Funding

the Research Project of Basic Scientific Research Operating Expenses of Provincial Colleges and Universities in Heilongjiang Province 2022-KYYWF-0788
6 · The paper itself

Abstract

Isoniazid (INH) and pyrazinamide (PZA) are both the first-line anti-tuberculosis drugs in clinical treatment. It is notable that there are serious side effects of the drugs along with upregulation of reactive nitrogen species, mainly including peripheral neuritis, gastrointestinal reactions, and acute drug-induced liver injury (DILI). Among them, DILI is the most common clinical symptom as well as the basic reason of treatment interruption, protocol change, and drug resistance. As vital reactive nitrogen species (RNS), peroxynitrite (ONOO

Indexed as

Antitubercular AgentsChemical and Drug Induced Liver InjuryAnimalsFluorescent DyesHeLa CellsHumansIsoniazidMicePeroxynitrous AcidPyrazinamideZebrafishAntitubercular AgentsFluorescent DyesIsoniazidPeroxynitrous AcidPyrazinamideAnti-tuberculosis drugsCell imagingLiver injuryNear-infrared fluorescent probePeroxynitrite (ONOO-)

Identifiers

PMID37801118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.